152 related articles for article (PubMed ID: 23674785)
1. Measurement of Tissue interstitial volume in healthy patients and those with amyloidosis with equilibrium contrast-enhanced MR imaging.
Bandula S; Banypersad SM; Sado D; Flett AS; Punwani S; Taylor SA; Hawkins PN; Moon JC
Radiology; 2013 Sep; 268(3):858-64. PubMed ID: 23674785
[TBL] [Abstract][Full Text] [Related]
2. Measurement of liver and spleen interstitial volume in patients with systemic amyloid light-chain amyloidosis using equilibrium contrast CT.
Yeung J; Sivarajan S; Treibel TA; Rosmini S; Fontana M; Gillmore JD; Hawkins PN; Punwani S; Moon JC; Taylor SA; Bandula S
Abdom Radiol (NY); 2017 Nov; 42(11):2646-2651. PubMed ID: 28567484
[TBL] [Abstract][Full Text] [Related]
3. Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study.
Fontana M; Banypersad SM; Treibel TA; Abdel-Gadir A; Maestrini V; Lane T; Gilbertson JA; Hutt DF; Lachmann HJ; Whelan CJ; Wechalekar AD; Herrey AS; Gillmore JD; Hawkins PN; Moon JC
Radiology; 2015 Nov; 277(2):388-97. PubMed ID: 25997029
[TBL] [Abstract][Full Text] [Related]
4. Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping.
Ioannou A; Patel RK; Martinez-Naharro A; Razvi Y; Porcari A; Hutt DF; Bandera F; Kotecha T; Venneri L; Chacko L; Massa P; Hanger M; Knight D; Manisty C; Moon J; Quarta C; Lachmann H; Whelan C; Kellman P; Hawkins PN; Gillmore JD; Wechelakar A; Fontana M
JACC Cardiovasc Imaging; 2023 Aug; 16(8):1038-1052. PubMed ID: 37178079
[TBL] [Abstract][Full Text] [Related]
5. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.
Banypersad SM; Sado DM; Flett AS; Gibbs SD; Pinney JH; Maestrini V; Cox AT; Fontana M; Whelan CJ; Wechalekar AD; Hawkins PN; Moon JC
Circ Cardiovasc Imaging; 2013 Jan; 6(1):34-9. PubMed ID: 23192846
[TBL] [Abstract][Full Text] [Related]
6. Myocardial Extracellular Volume Fraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging.
Lee HJ; Im DJ; Youn JC; Chang S; Suh YJ; Hong YJ; Kim YJ; Hur J; Choi BW
Radiology; 2016 Jul; 280(1):49-57. PubMed ID: 27322972
[TBL] [Abstract][Full Text] [Related]
7. Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction.
Campbell-Washburn AE; Price AN; Ellmerich S; Simons JP; Al-Shawi R; Kalber TL; Ghatrora R; Hawkins PN; Moon JC; Ordidge RJ; Pepys MB; Lythgoe MF
Amyloid; 2013 Jun; 20(2):93-8. PubMed ID: 23621497
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Magnetic Resonance-Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic Amyloid.
Chacko L; Boldrini M; Martone R; Law S; Martinez-Naharrro A; Hutt DF; Kotecha T; Patel RK; Razvi Y; Rezk T; Cohen OC; Brown JT; Srikantharajah M; Ganesananthan S; Lane T; Lachmann HJ; Wechalekar AD; Sachchithanantham S; Mahmood S; Whelan CJ; Knight DS; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
Circ Cardiovasc Imaging; 2021 Apr; ():CIRCIMAGING121012506. PubMed ID: 33876651
[TBL] [Abstract][Full Text] [Related]
9. Extracellular volume with bolus-only technique in amyloidosis patients: Diagnostic accuracy, correlation with other clinical cardiac measures, and ability to track changes in amyloid load over time.
Zumbo G; Barton SV; Thompson D; Sun M; Abdel-Gadir A; Treibel TA; Knight D; Martinez-Naharro A; Thirusha L; Gillmore JD; Moon JC; Hawkins PN; Fontana M
J Magn Reson Imaging; 2018 Jun; 47(6):1677-1684. PubMed ID: 29159946
[TBL] [Abstract][Full Text] [Related]
10. Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging.
Barison A; Aquaro GD; Pugliese NR; Cappelli F; Chiappino S; Vergaro G; Mirizzi G; Todiere G; Passino C; Masci PG; Perfetto F; Emdin M
J Intern Med; 2015 May; 277(5):605-14. PubMed ID: 25346163
[TBL] [Abstract][Full Text] [Related]
11. Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings.
Bandula S; White SK; Flett AS; Lawrence D; Pugliese F; Ashworth MT; Punwani S; Taylor SA; Moon JC
Radiology; 2013 Nov; 269(2):396-403. PubMed ID: 23878282
[TBL] [Abstract][Full Text] [Related]
12. T1 mapping and survival in systemic light-chain amyloidosis.
Banypersad SM; Fontana M; Maestrini V; Sado DM; Captur G; Petrie A; Piechnik SK; Whelan CJ; Herrey AS; Gillmore JD; Lachmann HJ; Wechalekar AD; Hawkins PN; Moon JC
Eur Heart J; 2015 Jan; 36(4):244-51. PubMed ID: 25411195
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease.
Sado DM; Flett AS; Banypersad SM; White SK; Maestrini V; Quarta G; Lachmann RH; Murphy E; Mehta A; Hughes DA; McKenna WJ; Taylor AM; Hausenloy DJ; Hawkins PN; Elliott PM; Moon JC
Heart; 2012 Oct; 98(19):1436-41. PubMed ID: 22936681
[TBL] [Abstract][Full Text] [Related]
14. Regional amyloid distribution and impact on mortality in light-chain amyloidosis: a T1 mapping cardiac magnetic resonance study.
Wan K; Li W; Sun J; Xu Y; Wang J; Liu H; Dong Y; Cheng W; Zhang Q; Zeng Z; Zhou X; Han Y; Chen Y
Amyloid; 2019 Mar; 26(1):45-51. PubMed ID: 30931628
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.
Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC
Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490
[TBL] [Abstract][Full Text] [Related]
16. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.
Hachulla E; Maulin L; Deveaux M; Facon T; Blétry O; Vanhille P; Wechsler B; Godeau P; Levesque H; Hatron PY; Huglo D; Devulder B; Marchandise X
Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719
[TBL] [Abstract][Full Text] [Related]
17. Equilibrium contrast-enhanced CT imaging to evaluate hepatic fibrosis: initial validation by comparison with histopathologic sampling.
Bandula S; Punwani S; Rosenberg WM; Jalan R; Hall AR; Dhillon A; Moon JC; Taylor SA
Radiology; 2015 Apr; 275(1):136-43. PubMed ID: 25490188
[TBL] [Abstract][Full Text] [Related]
18. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis.
Thomassin-Naggara I; Bazot M; Daraï E; Callard P; Thomassin J; Cuenod CA
Radiology; 2008 Jul; 248(1):148-59. PubMed ID: 18458244
[TBL] [Abstract][Full Text] [Related]
19. Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis.
Thuny F; Lovric D; Schnell F; Bergerot C; Ernande L; Cottin V; Derumeaux G; Croisille P
Radiology; 2014 May; 271(2):373-80. PubMed ID: 24475856
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of new subtraction algorithm in estimating degree of liver fibrosis by calculating extracellular volume fraction obtained from routine liver CT protocol equilibrium phase data: Preliminary experience.
Shinagawa Y; Sakamoto K; Sato K; Ito E; Urakawa H; Yoshimitsu K
Eur J Radiol; 2018 Jun; 103():99-104. PubMed ID: 29803393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
